Hao-Tian Lin, an eligible candidate for Member of the Chinese Academy of Sciences (2025) and Fellow of the Chinese Society of Biomedical Engineering, currently serves as Director of Zhongshan Eye Center and President of the Affiliated Eye Hospital, Sun Yat-sen University; Director of the WHO Collaborating Centre for Visual Health; Director of the National Key Laboratory of Ophthalmology Prevention and Treatment; and Director of the National Ophthalmology Quality Control Center (Preparatory Office). He holds the academic titles of Grade 2 Professor, Grade 1 Chief Physician, and Researcher, and serves as a doctoral supervisor in both ophthalmology and biomedical engineering. He is recognized as a National High-Level Talent, an Outstanding Young and Middle-aged Expert with Prominent Contributions by the National Health Commission, a recipient of the China Youth May Fourth Medal, and a Chief Scientist of the National Key R&D Program (with excellent project conclusion).

In terms of social positions, Professor Lin is Standing Committee Member of the All-China Youth Federation (Deputy Chairman of the Medical and Health Sector), Vice President of the China Association of Young Scientists and Technologists (Chairman of the Medical and Health Sector), Deputy Leader of the National Technical Committee for Medical Device Reliability and Maintainability Standardization, Standing Committee Member of the Ophthalmology Branch of the Chinese Medical Association, Vice President of the Guangdong Medical Association and Founding Chairman of its Medical Artificial Intelligence Branch, and President of the Guangdong Young Scientists Association.

Professor Lin has established a comprehensive system for artificial intelligence (AI)-assisted diagnosis, treatment, and clinical application in ophthalmology, achieving breakthroughs in three key areas: 1) addressing critical issues in data governance and security protection, laying a solid foundation for innovation in intelligent diagnosis and treatment technologies; 2) driving technological breakthroughs in intelligent screening and diagnosis of ocular and systemic diseases through algorithm innovations based on dynamic and static ocular features; and 3) constructing a novel intelligent "three-level diagnosis and treatment" model for eye diseases, enabling multi-scenario applications in ophthalmic care. He has presided over numerous national-level research projects, including key projects supported by the Major Research Plan of the National Natural Science Foundation of China and smart diagnosis and treatment projects for major diseases.

Academically, Professor Lin has published over 200 papers in top international journals such as Nature, Nature Medicine, Science, Lancet, BMJ, Nature Biomedical Engineering, and Lancet Digital Health. His research findings have been incorporated into 2 international guidelines, and he has edited 10 monographs, led the formulation of more than 10 application standards and specifications, obtained 60 domestic and international patents, and 12 software copyrights, with 5 achievements successfully transformed and applied in clinical practice. His work was recognized by Nature Medicine as one of the "Eight Breakthroughs in Life Medicine in 2016" and by IEEE Spectrum as one of the "11 AI Events Impacting Global Medicine". He has received numerous prestigious awards, including the De Ocampo Award (the highest academic award in Asia-Pacific ophthalmology), the First-Class Award of Guangdong Provincial Science and Technology Progress, the First-Class Award of Wu Wenjun Artificial Intelligence Science and Technology Progress, and the First Zhong Nanshan Youth Science and Technology Innovation Award中山大学. His technological achievements have been widely applied in representative medical institutions at all levels across China and in countries and regions along the "Belt and Road", benefiting tens of millions of residents and patients, leading the innovation and development of key intelligent technologies for eye disease prevention and treatment, and improving the overall level of ophthalmic care.